+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BIOCON
₹427.80 +1.45 (0.34%)
Near 52W High of ₹447.15

10 Aug, 2026 9:32 AM (IST)

Biocon live price: ₹427.80. It opened at ₹426 vs previous close ₹426; intraday high/low: ₹430/₹425. The 50 & 200 DMA stand at ₹420.90/₹394.60.

Biocon Performance

  • Today's Low
  • ₹425
  • Today's High
  • ₹430
  • 52 Week Low
  • ₹331
  • 52 Week High
  • ₹447
  • Open Price₹426
  • Previous Close₹426
  • Volume213,675
  • 50 DMA₹420.90
  • 100 DMA₹409.10
  • 200 DMA₹394.60

Biocon Chart

Investment Returns

  • Over 1 Month + 6.01%
  • Over 3 Month + 12.46%
  • Over 6 Month + 14.4%
  • Over 1 Year + 24.6%

Smart Investing Starts Here Start SIP with Biocon for Steady Growth!

Invest Now

Biocon Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 140.8
  • PEG Ratio
  • 4.9
  • Market Cap Cr
  • 69,718
  • P/B Ratio
  • 2
  • Average True Range
  • 10.7
  • EPS
  • 3
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 1.8
  • RSI
  • 49.64
  • MFI
  • 40.21

Latest Stock News Updates

Biocon Ltd - 532523 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Voting Results and Scrutinizer''s report

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Investor Meet

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement

Biocon Financials

Biocon Technicals

EMA & SMA

Current Price
₹427.80
+ 1.45 (0.34%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹428.10
  • 50 Day
  • ₹420.90
  • 100 Day
  • ₹409.10
  • 200 Day
  • ₹394.60

Resistance and Support

427.57 Pivot Speed
  • R3 444.20
  • R2 440.20
  • R1 433.30
  • S1 422.40
  • S2 418.40
  • S3 411.50

Biocon Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-05 Quarterly Results
2026-05-07 Audited Results & Final Dividend
2026-02-12 Quarterly Results
2025-11-11 Quarterly Results
2025-10-01 Redemption (Part) of NCD Inter alia, it is proposed to consider early redemption of unlisted, secured, rated, redeemable, Non-Convertible Debentures (NCDs) of face value of INR 1,00,000/- each.
Date Purpose Remarks
2026-07-03 FINAL Rs.0.50 per share(10%)Final Dividend
2025-07-04 FINAL Rs.0.50 per share(10%)Final Dividend
2024-07-05 FINAL Rs.0.50 per share(10%)Final Dividend
2023-07-07 FINAL Rs.1.50 per share(30%)Final Dividend
2022-07-01 FINAL Rs.0.50 per share(10%)Final Dividend
View Biocon Dividend History Arrow

Biocon F&O

Biocon Shareholding Pattern

44.68%
23.75%
15.47%
8.14%
7.91%

About Biocon

Biocon limited is a biopharmaceutical company in India and it is Asia's largest biotechnology company. The company was founded by Kiran Mazumdar-Shaw in 1978 and is headquartered in Bengaluru, India. The company has more than 16,545 employees as on March 2023. It focuses on all phases of the product cycle from researching to development and then introducing them to the market. They mainly concentrate on the research and development of advanced therapies for the treatment of cancer, diabetes, and autoimmune disease. The company's medicines are helping the lives of patients in more than 120 countries by providing access to all their medicines and therapies. 

Some of Biocon's important brands in India are INSUGEN (rh-insulin), BIOMAb EGFR (Nimotuzumab), CANMAb (Trastuzumab),KRABEVA (Bevacizumab), ALZUMAb(Itolizumab), BLISTO (Glimepiride + Metformin), BASALOG (Glargine) & so on. 

View More
  • NSE Symbol
  • BIOCON
  • BSE Symbol
  • 532523
  • Managing Director,Chief Executive Officer
  • Mr. Shreehas Tambe
  • ISIN
  • INE376G01013

Similar Stocks to Biocon

Biocon FAQs

Biocon share price is ₹427 As on 10 August, 2026 | 09:18

The Market Cap of Biocon is ₹69718.3 Cr As on 10 August, 2026 | 09:18

The P/E ratio of Biocon is 140.8 As on 10 August, 2026 | 09:18

The PB ratio of Biocon is 2 As on 10 August, 2026 | 09:18

The 52 week High & Low of Biocon is ₹447.2/₹331 respectively As on 10 August, 2026 | 09:18

Biocon has an operating revenue of Rs.7,290.70 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 16% is great. However, analysts are of mixed views on the stock.

Biocon Ltd. has declared 17 dividends since July 1, 2004.

The stock price CAGR of Biocon Limited for 10 Years is 24%, 5 Years is 17%, 3 Years is 5%, 1 Year is -21%.

The debt-to-equity ratio of Biocon Limited is 39% which signals a healthy balance sheet.

The ROE of Biocon Limited is 9% which is fair but needs improvement.

Mr. Siddharth Mittal is the Managing Director and CEO of Biocon Limited.

The company's shares can be bought online by opening a demat account with 5paisa in either web or app.

According to the record analysis of moneyworks4me, Biocom limited is an average quality company. 

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23